AIQ Solutions has a medical software platform that provides unique intelligence about oncology treatment effectiveness and toxicity risk. The platform analyzes longitudinal patient data to evaluate treatment response heterogeneity. AIQ has the ONLY technology that can quantify and characterize treatment response for each individual lesion and organ system. With this intelligence, AIQ software can make early predictions of treatment effectiveness and toxicity risk.
Pharma and biotech companies are using AIQ’s technology in early stage studies to better understand pharmacodynamic effects, toxicity risk, and mechanisms of resistance. Hospital systems use AIQ's technology to make real-time adjustments to patient therapy.
Pharma and biotech companies are using AIQ’s technology in early stage studies to better understand pharmacodynamic effects, toxicity risk, and mechanisms of resistance. Hospital systems use AIQ's technology to make real-time adjustments to patient therapy.
Location: United States, Wisconsin, Madison
Employees: 11-50
Phone: +1 608-268-9684
Total raised: $2M
Founded date: 2016
Investors 3
| Date | Name | Website |
| - | Capital Mi... | capitalmid... |
| 17.12.2025 | New York A... | newyorkang... |
| - | Rock River... | rockriverc... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 04.05.2022 | Grant | $2M | - |
Mentions in press and media 2
| Date | Title | Description |
| 05.06.2021 | Meet the startups taking part in the Health IT track for INVEST Precision Medicine Pitch Perfect | The INVEST Precision Medicine conference June 9-11, which will be held online, will explore a wide range of topics from advancing breakthrough therapies for rare disease and cancer, genetic testing, health equity, pediatric innovation and m... |
| - | Meet the startups taking part in the Health IT track for INVEST Precision Medicine Pitch Perfect | The INVEST Precision Medicine conference June 9-11, which will be held online, will explore a wide range of topics from advancing breakthrough therapies for rare disease and cancer, genetic testing, health equity, pediatric innovation and m... |